Sunesis Pharmaceuticals Inc (SNSS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Return on Assets (%) | -84.275 | -91.424 | -107.193 | -88.768 | -71.453 | -174.147 | -48.104 | -66.881 |
| Return on Equity (%) | -157.065 | -166.595 | -208.443 | -147.958 | -91.028 | -200.794 | -63.286 | -128.574 |
| Return on Invested Capital (%) | -122.515 | -131.649 | -213.867 | -148.686 | -95.82 | -197.198 | -55.917 | -100.179 |
| Operating Margin (%) | -1431.467 | -5091.48 | -10743.038 | -1100.627 | -17756.667 | N/A | N/A | N/A |
| Net Profit Margin (%) | -1499.33 | -5300.149 | -11229.958 | -1125.422 | -18008.333 | N/A | N/A | N/A |
| Book Value Per Share | 1.005 | 0.628 | 0.107 | 0.142 | 0.795 | 2.375 | 1.451 | 0.333 |
| Earnings Per Share | -1.817 | -1.034 | -0.71 | -0.209 | -1.193 | -3.066 | -1.283 | -1.322 |
| Cash Per Share | 0.385 | 0.787 | 0.365 | 0.115 | 1.127 | 2.766 | 0.959 | 0.319 |
| Working Capital Per Share | 1.543 | 0.591 | 0.103 | 0.242 | 1.04 | 2.569 | 2.183 | 0.429 |
| Operating Profit Per Share | 0.121 | 0.02 | 0.006 | 0.019 | 0.007 | 0.361 | N/A | N/A |
| EBIT Per Share | -1.817 | -1.034 | -0.71 | -0.209 | -1.193 | -3.066 | -1.283 | -1.322 |
| EBITDA Per Share | -1.817 | -1.034 | -0.71 | -0.209 | -1.193 | -3.066 | -1.283 | -1.322 |
| Free Cash Flow Per Share | -1.818 | -1.034 | -0.71 | -0.209 | -1.193 | -2.957 | -1.287 | -1.331 |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Shares Outstanding | 20.93M | 34.29M | 37.47M | 111.39M | 18.11M | 37.43M | 38.35M | N/A |
| Year End December 30 2023 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Shares Outstanding | 37.9M | 38.35M | N/A | N/A | N/A | N/A | N/A | 39.42M |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 205.49M |
| Price to Earnings Ratio | -0.14 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.6 |
| Price to Book Ratio | 0.4 |
| Dividend Yield | - |
| Shares Outstanding | 38.63M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
